INTRODUCTION
CCCTC-binding factor (CTCF) is a ubiquitously expressed and evolutionarily conserved zinc finger (ZF) protein that binds target sites through combinatorial use of its 11 ZFs in eukaryote, which plays diverse roles including promoter activation or repression, gene silencing, chromatin insulation, gene imprinting and X-chromosome inactivation (Bell et al., 1999; Chao et al., 2002; Klenova et al., 2002; Lutz et al., 2000; Szabo et al., 2000; Zlatanova and Caiafa, 2009) . As an important transcription regulation factor interrelated to cell proliferation and tumorgenesis, CTCF nuclear translocation is an important process. However researchers concentrated their attention to the function of CTCF, the molecular mechanism by which CTCF enters the nucleus is unknown.
Previous researches indicate that CTCF is localized in the nucleus in the majority of cells, independently of its phosphorylation state (Klenova et al., 1993; 2001) . The CTCF subcellular distribution during the cell cycle is dynamic and it has been found associated with mitotic chromosomes, mitotic centrosomes as well as the midbody of the cytokinesis, suggesting different roles for CTCF at different stages of the cell cycle (Burke et al., 2005; Zhang et al., 2004) . Besides, Torrano et al. (2006) found nucleolar localization of CTCF is associated with growth arrest through a poly(ADP-ribosyl)ation-dependent mechanism. Further, investigations of CTCF expression pattern in 344 cases of invasive breast carcinoma showed that intracellular distribution of CTCF is significantly correlated with the histological grades. Cytoplasmic distribution was associated with grade III tumors and vascular invasion (Rakha et al., 2004) . Our previous studies also showed that CTCF was mostly located in nucleus in grade I and II tumors. However, CTCF was mostly located in the cytoplasm in grade III tumors. Interestingly, Docquier et al. found that CTCF levels were elevated in 15 breast cancer cell lines compared to normal human breast cell lines (Docquier et al., 2005) . However, the CTCF expression level was not consistent in these breast cancer cell lines. CTCF expression level in highly invasive breast cancer cells was much lower than that in the low invasive breast cancer cells. Therefore, we hypothesize that the expression level of CTCF affects the intracellular distribution of CTCF, which, in turn, influences the invasive capability of tumor cells. With regard to the mechanism by which CTCF expression influences its intracellular distribution, we speculate that CTCF regulates the expression of one or several proteins that are related to the transport of proteins with high molecular weight, which consequently regulates the nuclear import of CTCF. To identify the target genes regulated by CTCF, we used the CHIP-on-chip technique, and detected a target gene encoding Importin 13 (IPO13) which is one of members of Karyopherins superfamily which plays an important role in nucleocytoplasmic transport.
Nucleocytoplasmic transport is an essential activity in eukaryotic cells. For example, mRNAs and tRNAs are produced in the nuclear compartment and need to be exported to the cytoplasm where they function in translation. Conversely, all nuclear proteins are imported from the cytoplasm where they are produced. Nuclear transport proceeds through nuclear pore complexes (NPCs). Small molecules go through NPCs directly, while molecules larger than 50 kDa have to be actively transported via soluble nuclear transport receptors (NTRs) bind spe-
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http://molcells.org Mol. Cells 389 cific amino acid residues or sequence elements within the cargo protein (Cook et al., 2007; Görlich and Kutay, 1999; Terry et al., 2007; Weis, 2003 ). Therefore, we hypothesized that IPO13 might also mediate the nuclear import of CTCF. In this paper, our results demonstrates that there is a CTCF target site in ipo13 -774~-573 bp promoter region and CTCF regulates the expression of IPO13. GST pull-down and Co-IP experiments demonstrates that CTCF interacts with IPO13. Immunofluorescence staining shows that IPO13 influenced intracellular distribution of CTCF. We conclude that CTCF regulates the expression of IPO13, which, in turn, mediates the nuclear import of CTCF.
MATERIALS AND METHODS

Cell lines
Human breast cancer cell lines (MDA-MB-453, MDA-MB-231, MDA-MB-157, BT474, MCF7, MCF7B and LCC1), human hepatoma carcinoma cell lines (SMMC-7721 and HepG2), human uterine cervix cancer cell line (HeLa) and human embryo kidney cell line (293FT) were purchased from the cell culture center of Institute of Basic Medical Sciences (IBMS). MDA-MB-231 and MDA-MB-157 cell lines were maintained in L-15 medium supplemented with 15% fetal calf serum (FCS). SMMC-7721 cell line was maintained in RPMI 1640 medium supplemented with 10% FCS, and other cell lines were maintained in DMEM medium supplemented with 10% FCS (all from GIBCO). These cell lines were grown in a humidified 5% CO 2 -containing atmosphere at 37°C.
Expression vectors, siRNA and primers
The plasmids expressing CTCF protein (pCMV6-XL5-CTCF) and IPO13 protein (pCMV-SPORT6-IPO13) were purchased from ORIGENE. Glutathione-S-transferase (GST) fusion with IPO13 was generated by inserting ORF of ipo13 (L: 5′-TT GAATTCGAGCGGCGGGAGGAGCAGCCG-3′; R: 5′-GCCTC GAGTTATCAGTAGTCAGCTGTGTAA-3′; EcoRI and XhoI) into pGEX-4T-1 vector (Amersham Biosciences). The plasmid expressing CTCF protein in 293FT was constructed by inserting the ORF of ctcf (L: 5′-CCGGAATTCGGATGGAAGGTGA TGCAGTCGA-3′; R: 5′-AGAAATGCGGCCGCTCACCGGTCC ATCATGCTGA-3′; EcoRI and NotI) into pCMV-HA.
The oligonucleotide sequences for RNAi of ctcf and ipo13 were shown below. The preparation for siRNA was described previously (Zhu et al., 2005) . luciferase：caCTTACGCTGAGTACTTCGA CTCF #1：aaGGAAAGGAGAGAAAGACTT CTCF #2：aaCGTCACATTCGCTCTCATA IPO13 #1：aaGTAGAGCACTGGCAGAGTT IPO13 #2：aaGGAGCAGTTCCGAATTTAC IPO13 #3：aaGTGGAGGAGATCCTTAAGA
The primers for RT-PCR were shown below:
GST pull-down GST fusion proteins were incubated with magnetic glutathione particles (Promega, USA), which were balanced in 1× PBS (pH 7.4) for 0.5 h at room temperature. After washing, beads were incubated with CTCF, which was over expressed in 293FT by transient transfection, for 1 h at room temperature. After washing, proteins on beads were eluted by boiling in 1× SDS-PAGE sample buffer and examined by Western blot.
Co-immunoprecipitation (Co-IP)
Extracts of 293FT cells transfected with plasmids encoding CTCF and IPO13, or HepG2 cells were prepared in RIPA lysis buffer containing 50 mmol/L Tris (pH 7.6), 150 mmol/L sodium chloride, 1% Triton X-100 and 2 mmol/L PMSF. The cell lysate was pre-cleaned by incubating with 50 μl Protein G-Agarose (Roche) at 4°C for at least 3 h. The pre-cleaned cell lysate was incubated with 5 μg anti-CTCF antiserum or anti-IPO13 polyclonal antibody or Normal Rabbit IgG at 4°C for 1 h. Subsequently, 50 μl Protein G-Agarose was added and incubated at 4°C for approximately 16 h. The beads were spun down, washed with Wash Buffer I, II, III (Roche) for several times. Finally, proteins on the beads were eluted by boiling in 1× SDS-PAGE sample buffer and examined by Western blot.
Chromatin immunoprecipitation (CHIP)
CHIP was performed using CHIP-IT Express Enzymatic Kit (Active Motif) following the manufacturer's instruction. Using a sonicator with 25% power, chromatin was sheared by ten pulses (20 s for each pulse) with a 30-second rest on ice between each pulse. CHIP reaction contained 25 μl Protein G Magnetic Beads, 10 μl CHIP Buffer 1, 0.6 μg sheared chromatin, 1 μl PIC, 3 μg antibody (anti-CTCF antiserum or Normal Rabbit IgG), and dH 2 O to achieve a total volume of 100 μl. The primers used for CHIP-PCR were shown below: IPO13 5L 5′-AGCAAAGTCCTGCTCCTAGC-3′ IPO13 5R 5′-CACCACCCAGAGAAGAGGAG-3′
Immunofluorescence (IF)
Transfected cells were trypsinized into cell suspension, and then transferred to glass slide in a culture dish. After 24 h, the cells were fixed in fixation solution (methanol: acetone = 1:1) for 10 min at room temperature. After washing with 1× PBS, the cells were incubated with primary antibody (anti-CTCF antiserum, 1:200 in 3% BSA/PBS) for overnight at 4°C. After washing with 1× PBS, the cells were incubated with secondary antibody
